The SITS-UTMOST: A registry-based prospective study in Europe investigating the impact of regulatory approval of intravenous Actilyse in the extended time window (3–4.5 h) in acute ischaemic stroke

INTRODUCTION: The SITS-UTMOST (Safe Implementation of Thrombolysis in Upper Time window Monitoring Study) was a registry-based prospective study of intravenous alteplase used in the extended time window (3–4.5 h) in acute ischaemic stroke to evaluate the impact of the approval of the extended time w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Stroke J
Autors principals: Ahmed, Niaz, Hermansson, Karin, Bluhmki, Erich, Danays, Thierry, Nunes, Ana Paiva, Kenton, Anthony, Lakshmanan, Sekaran, Toni, Danilo, Mikulik, Robert, Ford, Gary A, Lees, Kennedy R, Wahlgren, Nils
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2016
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6301239/
https://ncbi.nlm.nih.gov/pubmed/31008282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2396987316661890
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars